ATYR Pharma
ATYR----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: ATYR Pharma(ATYR) predict that the EBIT is -11.44 M (+27.5%), Beat estimate;the EPS is -0.11 (+35.29%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B27.50%
-0.01B5.64%
+0.00B21.86%
EPSExceed expectations
-0.1135.29%
-0.137519.12%
+0.027516.17%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf